IOLCP Announces Special Window for Dematerialisation of Physical Securities
IOLCP opens a Special Window from February 5, 2026, to February 4, 2027, for dematerialisation of physical securities. This applies to shares with transfer deeds executed before April 1, 2019. Processed shares will have a one-year lock-in period.
This is a routine regulatory compliance announcement related to share transfer and dematerialisation processes. It does not involve any significant financial transactions, business strategy changes, or operational updates that would materially impact the company's stock or business operations.
The announcement is a procedural update regarding a special window for dematerialisation of physical securities and does not contain any financial performance data or strategic business developments that would indicate a positive or negative sentiment.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has announced a Special Window for the transfer and dematerialisation of physical securities. This initiative, in line with SEBI Circular No. H0/38/13/11(2)2026-MIRSD-POD/1/3750/2026 dated 30th January 2026, will remain open from 5th February 2026 to 4th February 2027.
The special window is applicable for physical shares where the original transfer deed was executed before 1st April 2019, and the share transfer request was either returned, rejected, or remained unattended due to documentation deficiencies, or if the share transfer request was not lodged prior to 1st April 2019, and the shareholder still holds the original share certificate with a duly executed transfer deed.
All shares re-lodged for transfer during this period will be processed exclusively in dematerialised form. The securities transferred will be subject to a lock-in period of one year from the date of registration of transfer, during which they cannot be transferred, lien-marked, or pledged. Shareholders are advised to submit their re-lodgment requests along with all requisite documents to the Company's Registrar and Share Transfer Agent, Alankit Assignments Limited, at their New Delhi address. The company has also published this notice in the Financial Express (English) and Punjabi Jagran (Punjabi) on 18th February 2026.
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under share transfer updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.